Narek Pharmaceuticals

CIK 1363584 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Narek Pharmaceuticals.

Recent SEC filings

FiledFormAccession number
Mar 8, 2013REVOKED9999999997-13-002210
Jun 17, 20088-K/A0001158957-08-000178
May 15, 2008NT 10-Q0001158957-08-000121
Mar 31, 2008NT 10-K0001158957-08-000077
Jan 22, 200810QSB/A0001144204-08-003196
Jan 22, 20088-K0001144204-08-003192
Nov 19, 200710QSB0001144204-07-062941
Nov 16, 2007SC 13D/A0001144204-07-062438
Nov 16, 200740001144204-07-062436
Nov 15, 2007NT 10-Q0001144204-07-062107
Nov 14, 20078-K0001144204-07-061321
Oct 12, 2007SC 14F10001144204-07-053924
Aug 13, 200710QSB0001144204-07-042482
May 15, 200710QSB0001144204-07-025329
Mar 30, 200710KSB0001144204-07-015546
Nov 13, 200610QSB0001144204-06-046636
Sep 8, 200610QSB0001144204-06-037564
Jul 27, 200630001144204-06-029852
Jul 27, 2006SC 13D0001144204-06-029855
May 26, 200610SB12G0001144204-06-022754